Glide Pharma Raises Third Round

Glide Pharma, a UK-based developer of a needle-less durg delivery system, has raised Gbp2.3 million in third-round funding. Oxford Capital Partners was joined by return backers Oxford Technology 4 VCT. Gilde previously had raised a total of Gbp2.6 million. www.glidepharma.com